Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

NCT02811783 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

59

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Mycosis Fungoides
Lymphoma, T-Cell, Cutaneous
Sézary Syndrome

Interventions

DRUG: Naloxone Hydrochloride Lotion, 0.5%
DRUG: Placebo Lotion

Sponsor

Elorac, Inc.